RHEUMATOLOGY

Leonard Calabrese, DO, on Key Topics at the Interdisciplinary Autoimmune Summit

03/25/2019

In this podcast, Leonard Calabrese, DO, highlights important topics that will be covered at the Interdisciplinary Autoimmune Summit (IAS) and how the meeting addresses the intersection between immune diseases in rheumatology, gastroenterology, and dermatology.

Leonard Calabrese, DO, is Vice Chairman of the Department of Rheumatic and Immunologic Diseases and Head of the Section of Clinical Immunology at the Cleveland Clinic Foundation in Cleveland, Ohio.

For more information about IAS 2019 meeting, please visit https://www.iasmeeting.com/.

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

Videos

Joshua Baker, MD, on the Risk of Diabetes Among Patients With RA

07/29/2021

In this video, Dr Joshua Baker, an assistant professor of rheumatology and epidemiology at the University of Pennsylvania, discusses the risk of diabetes among patients with rheumatoid arthritis.

In this video, Dr Joshua Baker,...

07/29/2021

Rheumatology & Arthritis

Videos

Trials in Rheumatology: IL-6 and Beyond

02/08/2021

In this video, Leonard Calabrese, DO, and Cassandra Calabrese, DO, discuss their experiences with the COVID-19 pandemic, including the ongoing drug trials at the Cleveland Clinic. Read the transcript here. Additional Resource:

In this video, Leonard...

02/08/2021

Rheumatology & Arthritis

Videos

A Preview of the ACR Guideline for the Management of JIA

12/01/2020

The American College of Rheumatology (ACR) guideline for the management of juvenile idiopathic arthritis (JIA) is currently under review and will soon be published. In this video, the lead investigator of the guideline’s Core Team, Karen...

The American College of...

12/01/2020

Rheumatology & Arthritis

FDA Approves Treatment Option for Polyarticular Course JIA

10/01/2020

The US Food and Drug Administration (FDA) has approved Xeljanz (tofacitinib) for the treatment of active polyarticular course juvenile idiopathic arthritis (pcJIA) among pediatric patients aged 2 years or older. The...

The US...

10/01/2020

Rheumatology & Arthritis

Which Patients With Psoriasis Are More Likely to Develop PsA?

06/26/2020

Patients with psoriasis who also have structural entheseal lesions, even when they have no clinical symptoms of musculoskeletal disease, are at a higher risk of developing psoriatic arthritis (PsA) than patients...

Patients...

06/26/2020

Rheumatology & Arthritis

Leonard Calabrese, DO, on Key Topics at the Interdisciplinary Autoimmune Summit

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products